Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines

被引:0
|
作者
Fujishita, T [1 ]
Mizushima, Y [1 ]
Kashii, T [1 ]
Kobayashi, M [1 ]
机构
[1] Toyama Med & Pharmaceut Univ, Dept Internal Med 1, Sugitani, Toyama 93001, Japan
关键词
lung cancer; CDK inhibitor genes; K-ras p53;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclin-dependent kinase (CDK) inhibitor genes have recently been proposed as new tumor suppressor genes. To define the possible participation of CDK inhibitor genes in lung carcinogenesis, we investigated the alterations of p15(INK4B), p16(INK4A), p21(Waf1), and p27(Kip1) genes in 34 human lung cancer cell lines using the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP), direct sequencing, and southern dot blot methods. Among the four CDK inhibitor genes, alterations of only the p16(INK4A) gene were found in 8 out of 34 (24%) cell lines, and all eight cell lines having a p16(INK4A) gene alteration had an alteration of either the K-ras or p53 gene. Conversely, p16(INK4A) gene alterations were found in none of the 3 cell lines having Rb gene alterations and none of the 3 cell lines having amplification of the N-myc gene. Polymorphism was found in both p21(Waf1) and p27(Kip1) genes, but no association was found between the polymorphism and alterations of other genes. These results suggest that p16(INK4A) gene alterations may play a certain role for lung carcinogenesis in co-operation with either K- ras orp53 gene alterations.
引用
收藏
页码:1537 / 1542
页数:6
相关论文
共 50 条
  • [41] Predicting Functional Significance of Cancer-Associated p16INK4a Mutations in CDKN2A
    McKenzie, Heather A.
    Fung, Carina
    Becker, Therese M.
    Irvine, Mal
    Mann, Graham J.
    Kefford, Richard F.
    Rizos, Helen
    HUMAN MUTATION, 2010, 31 (06) : 692 - 701
  • [42] CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis
    Aftab, Ayesha
    Shahzad, Shaheen
    Hussain, Hafiz Muhammad Jafar
    Khan, Ranjha
    Irum, Samra
    Tabassum, Sobia
    BREAST CANCER, 2019, 26 (01) : 11 - 28
  • [43] CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis
    Ayesha Aftab
    Shaheen Shahzad
    Hafiz Muhammad Jafar Hussain
    Ranjha Khan
    Samra Irum
    Sobia Tabassum
    Breast Cancer, 2019, 26 : 11 - 28
  • [44] Detection of RB, p16/CDKN2 and p15(INK4B) gene alterations with immunohistochemical studies in human prostate carcinomas
    Konishi, N
    Hiasa, Y
    Tsuzuki, T
    Matsuda, H
    Tao, M
    Nakamura, M
    Naito, H
    Kitahori, Y
    Shiraishi, T
    Yatani, R
    Shimazaki, J
    Lin, JC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (01) : 107 - 112
  • [45] Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma
    Merbs, SL
    Sidransky, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (03) : 779 - 783
  • [46] Analysis on point mutation of the cdkn2/p16 gene in lung cancer
    Su, Changqing
    Ye, Yukun
    Wang, Dong
    Cao, Xiangrong
    Li, Shufeng
    Shan, Xiangnian
    Chinese Journal of Medical Genetics, 2002, 19 (01) : 37 - 40
  • [47] Low frequency of p16INK4a alterations in insulinomas
    Bartsch, DK
    Kersting, M
    Wild, A
    Ramaswamy, A
    Gerdes, B
    Schuermann, M
    Simon, B
    Rothmund, M
    DIGESTION, 2000, 62 (2-3) : 171 - 177
  • [48] Frequent p16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors
    Li, JN
    Weghorst, CM
    Tsutsumi, M
    Poi, MJ
    Knobloch, TJ
    Casto, BC
    Melvin, WS
    Tsai, MD
    Muscarella, P
    CARCINOGENESIS, 2004, 25 (02) : 263 - 268
  • [49] MUTATIONS IN THE P16(INK4)/MTS1/CDKN2, P15(INK4B)/MTS2, AND P18 GENES IN PRIMARY AND METASTATIC LUNG-CANCER
    OKAMOTO, A
    HUSSAIN, SP
    HAGIWARA, K
    SPILLARE, EA
    RUSIN, MR
    DEMETRICK, DJ
    SERRANO, M
    HANNON, GJ
    SHISEKI, M
    ZARIWALA, M
    XIONG, Y
    BEACH, DH
    YOKOTA, J
    HARRIS, CC
    CANCER RESEARCH, 1995, 55 (07) : 1448 - 1451
  • [50] p16INK4A -: alterations in primary angiosarcoma of the liver
    Tannapfel, A
    Weihrauch, M
    Benicke, M
    Uhlmann, D
    Hauss, J
    Wrbitzky, R
    Wittekind, C
    JOURNAL OF HEPATOLOGY, 2001, 35 (01) : 62 - 67